- Home
- CLGN vs OPXS Comparison
CLGN vs OPXS Comparison
Compare CLGN & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- OPXS
- Stock Information
- Founded
- CLGN 2004
- OPXS 1987
- Country
- CLGN Israel
- OPXS United States
- Employees
- CLGN N/A
- OPXS N/A
- Industry
- CLGN Industrial Specialties
- OPXS Electronic Components
- Sector
- CLGN Health Care
- OPXS Technology
- Exchange
- CLGN Nasdaq
- OPXS Nasdaq
- Market Cap
- CLGN 22.1M
- OPXS 43.4M
- IPO Year
- CLGN N/A
- OPXS N/A
- Fundamental
- Price
- CLGN $3.18
- OPXS $8.53
- Analyst Decision
- CLGN Strong Buy
- OPXS
- Analyst Count
- CLGN 2
- OPXS 0
- Target Price
- CLGN $11.50
- OPXS N/A
- AVG Volume (30 Days)
- CLGN 165.3K
- OPXS 30.6K
- Earning Date
- CLGN 05-28-2025
- OPXS 05-13-2025
- Dividend Yield
- CLGN N/A
- OPXS N/A
- EPS Growth
- CLGN N/A
- OPXS 36.84
- EPS
- CLGN N/A
- OPXS 0.71
- Revenue
- CLGN $2,472,000.00
- OPXS $37,431,000.00
- Revenue This Year
- CLGN $2,177.67
- OPXS N/A
- Revenue Next Year
- CLGN $56.52
- OPXS N/A
- P/E Ratio
- CLGN N/A
- OPXS $12.03
- Revenue Growth
- CLGN N/A
- OPXS 21.76
- 52 Week Low
- CLGN $1.55
- OPXS $5.36
- 52 Week High
- CLGN $5.63
- OPXS $10.30
- Technical
- Relative Strength Index (RSI)
- CLGN 59.91
- OPXS 66.24
- Support Level
- CLGN $1.90
- OPXS $7.80
- Resistance Level
- CLGN $4.98
- OPXS $9.14
- Average True Range (ATR)
- CLGN 0.40
- OPXS 0.49
- MACD
- CLGN 0.25
- OPXS 0.04
- Stochastic Oscillator
- CLGN 47.52
- OPXS 75.07
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.